Last week, Trump put the onus on Biden for the economy contracting in the first quarter of the year.
Related Posts
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
It extends a tumultuous period for UnitedHealth marked by the killing of a top executive, a costly cyberattack against its subsidiary and high medical costs.
FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.